Land: Storbritannien
Språk: engelska
Källa: MHRA (Medicines & Healthcare Products Regulatory Agency)
Gabapentin
Accord-UK Ltd
N02BF01
Gabapentin
600mg
Oral tablet
Oral
Schedule 3 (CD No Register Exempt Safe Custody)
Valid as a prescribable product
BNF: 04080100; GTIN: 5060149319741
PACKAGE LEAFLET: INFORMATION FOR THE USER GABAPENTIN ACCORD 600 MG FILM-COATED TABLETS GABAPENTIN ACCORD 800 MG FILM-COATED TABLETS GABAPENTIN READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist or nurse. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects,talk to your doctor or pharmacist or nurse.This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET 1. What Gabapentin Film-coated tablets are and what they are used for 2. What you need to know before you take Gabapentin Film-coated tablets 3. How to take Gabapentin Film-coated tablets 4. Possible side effects 5. How to store Gabapentin Film-coated tablets 6. Content of the pack and other information 1. WHAT GABAPENTIN FILM-COATED TABLETS ARE AND WHAT THEY ARE USED FOR Gabapentin Film-coated tablets belong to a group of medicines used to treat epilepsy and peripheral neuropathic pain (long lasting pain caused by damage to the nerves). The active ingredient in Gabapentin Film-coated tablets is gabapentin. Gabapentin Film-coated tablets are used to treat: Various forms of epilepsy (seizures that are initially limited to certain parts of the brain, whether the seizure spreads to other parts of the brain or not). Your doctor will prescribe Gabapentin Film-coated tablets for you to help treat your epilepsy when your current treatment is not fully controlling your condition. You should take Gabapentin Film-coated tablets in addition to your current treatment unless told otherwise. Gabapentin Film-coated tablets can also be used on its own to treat adults and children over 12 years of age. Peripheral neuropathic pain (long lasting pain caused by damage to the nerves). A variety of different diseases can Läs hela dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Gabapentin 600mg tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 600 mg of gabapentin. Excipients with known effect: Each film-coated tablet contains 56 mg hydrogenated castor oil. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. White, film-coated tablet, oblong, biconvex, scored on both sides. The tablets can be divided into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Epilepsy Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and children aged 6 years and above (see section 5.1). _Gabapentin is indicated as monotherapy in the treatment of partial seizures with and _ _without secondary generalization in adults and adolescents aged 12 years and above. _ Treatment of peripheral neuropathic pain Gabapentin is indicated for the treatment of peripheral neuropathic pain such as painful diabetic neuropathy and post-herpetic neuralgia in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology For all indications a titration scheme for the initiation of therapy is described in Table 1, which is recommended for adults and adolescents aged 12 years and above. Dosing instructions for children under 12 years of age are provided under a separate sub-heading later in this section. Table 1 DOSING CHART – INITIAL TITRATION Day 1 Day 2 Day 3 300 mg once a day 300 mg two times a day 300 mg three times a day Discontinuation of gabapentin In accordance with current clinical practice, if gabapentin has to be discontinued it is recommended this should be done gradually over a minimum of 1 week independent of the indication. EPILEPSY Epilepsy typically requires long-term therapy. Dosage is determined by the treating physician according to individual tolerance and efficacy. _Adults and adolescents: _ In clinical trials, the effective dosing range was 900 to 3600 mg/day. Therapy may be Läs hela dokumentet